Literature DB >> 6838050

Primary pulmonary hypertension and cirrhosis: are they related?

P J McDonnell, P A Toye, G M Hutchins.   

Abstract

The relationship of primary pulmonary hypertension to longstanding portal hypertension secondary to hepatic cirrhosis was examined. An unselected series of 17,901 autopsied patients older than 1 yr of age showed that primary pulmonary hypertension occurred with a prevalence of 0.13% in all patients, but with a prevalence of 0.73% among patients with cirrhosis (p less than 0.001). A clinical series of 2,459 patients with biopsy-proved hepatic cirrhosis showed a prevalence of primary pulmonary hypertension of 0.61%, also significant (p less than 0.001) when compared with the prevalence among all patients older than 1 yr of age at autopsy. These data appear to exclude a coincidental association of cirrhosis with the development of the vascular lesions of primary pulmonary hypertension.

Entities:  

Mesh:

Year:  1983        PMID: 6838050     DOI: 10.1164/arrd.1983.127.4.437

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  33 in total

Review 1.  Pulmonary hypertension: its assessment and treatment.

Authors:  S Brij; A J Peacock
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.

Authors:  Ezequiel Balmori Melian; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Esophageal variceal ligation for esophageal variceal hemorrhage in a patient with portal and primary pulmonary hypertension complicating myelofibrosis.

Authors:  W C Lee; H C Lin; S H Tsay; Y Y Yang; M C Hou; F Y Lee; F Y Chang; S D Lee
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

4.  Portopulmonary hypertension in pediatric patients.

Authors:  Adria A Condino; D Dunbar Ivy; Judith A O'Connor; Michael R Narkewicz; Sarah Mengshol; John R Whitworth; Lori Claussen; Aimee Doran; Ronald J Sokol
Journal:  J Pediatr       Date:  2005-07       Impact factor: 4.406

Review 5.  Portopulmonary hypertension.

Authors:  Michael Halank; Ralf Ewert; Hans-Juergen Seyfarth; Gert Hoeffken
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

Review 6.  Epidemiology of pulmonary arterial hypertension.

Authors:  Xin Jiang; Zhi-Cheng Jing
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 7.  Appetite suppressants and pulmonary hypertension.

Authors:  N F Voelkel
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

8.  Pulmonary hypertension associated with primary biliary cirrhosis in the absence of portal hypertension: a case report.

Authors:  E M Yoshida; S R Erb; D N Ostrow; D R Ricci; C H Scudamore; G Fradet
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 9.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

10.  Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.

Authors:  Kari E Roberts; Michael B Fallon; Michael J Krowka; Robert S Brown; James F Trotter; Inga Peter; Hocine Tighiouart; James A Knowles; Daniel Rabinowitz; Raymond L Benza; David B Badesch; Darren B Taichman; Evelyn M Horn; Steven Zacks; Neil Kaplowitz; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2009-02-12       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.